Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blood-brain barrier
Biotech
Astellas pays Sangamo $20M to boost neurological gene therapies
Astellas continues to strengthen its neurological gene therapy capabilities, handing Sangamo $20 million upfront to bypass the blood-brain barrier.
James Waldron
Dec 19, 2024 7:13am
BMS pays Leqembi originator $100M for Alzheimer's prospects
Dec 19, 2024 5:23am
AbbVie inks $1.4B Aliada buyout to land ex-J&J Alzheimer's drug
Oct 28, 2024 10:00am
Denali reports new method to get ASOs across blood-brain barrier
Aug 14, 2024 2:00pm
A brain parasite has been turned into drug delivery system
Jul 29, 2024 2:55pm
Roche BTK inhibitor may show 'holy grail' of brain penetration
Oct 13, 2023 9:30am
